Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentian root is a botanical medicinal product derived from the dried rhizomes and roots of *Gentiana lutea*. It is widely recognized in pharmacopoeias as a bitter tonic (stomachic) used to treat digestive complaints such as dyspepsia, flatulence, and loss of appetite. The therapeutic effects are primarily attributed to secoiridoid glycosides, including gentiopicroside and amarogentin, which are among the most bitter substances known. These compounds stimulate bitter taste receptors (TAS2Rs) in the oral cavity, triggering a cephalic phase of digestion that increases the secretion of saliva, gastric juice, and bile. Beyond its use as a monotherapy, gentian root is a key component in several multi-herb pharmaceutical products, such as Sinupret, used for the treatment of acute and chronic sinusitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentian root.